Abstract
A series of novel 6-fluoro1,4-dihydro-4-oxo-3-quinoline carboxylic acid dimers (34-37), were synthesized as potential antibacterial agents from commercially available fluoro benzoic acids.
Keywords: 2,3,4,5-Tetraflurobenzoic acid, 2,4,5-Trifluoroacetophenone, anti bacterial agents, regiospecific dimeric cyclisation, STERMOL length, quinoline carboxylic acid dimers, cyclopropyl, ciprofloxacin., methylene, ofloxacin
Letters in Organic Chemistry
Title: Quinolone Dimers as Potential Antibacterial Agents
Volume: 8 Issue: 9
Author(s): Naveenkumar R. Chepyala, Rajashaker R. Durgi, Lakshmi K. Tatini, Gottumukkala V. Subbaraju, Rama M. Hindupur and Muralimohan R. Dhanvada
Affiliation:
Keywords: 2,3,4,5-Tetraflurobenzoic acid, 2,4,5-Trifluoroacetophenone, anti bacterial agents, regiospecific dimeric cyclisation, STERMOL length, quinoline carboxylic acid dimers, cyclopropyl, ciprofloxacin., methylene, ofloxacin
Abstract: A series of novel 6-fluoro1,4-dihydro-4-oxo-3-quinoline carboxylic acid dimers (34-37), were synthesized as potential antibacterial agents from commercially available fluoro benzoic acids.
Export Options
About this article
Cite this article as:
R. Chepyala Naveenkumar, R. Durgi Rajashaker, K. Tatini Lakshmi, V. Subbaraju Gottumukkala, M. Hindupur Rama and R. Dhanvada Muralimohan, Quinolone Dimers as Potential Antibacterial Agents, Letters in Organic Chemistry 2011; 8 (9) . https://dx.doi.org/10.2174/157017811799304322
DOI https://dx.doi.org/10.2174/157017811799304322 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Towards Multifunctional Synthetic Vectors
Current Gene Therapy Pharmacokinetics and Metabolism of Traditional Chinese Medicine in the Treatment of COVID-19
Current Drug Metabolism Enzyme Inhibitors
Current Bioactive Compounds NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites
Current Topics in Medicinal Chemistry Favipiravir in the Battle with Respiratory Viruses
Mini-Reviews in Medicinal Chemistry Inhibitory Effect of Ascorbic Acid on Glutathione S-transferase from Human Erythrocytes
Current Enzyme Inhibition Development and Validation of a Sensitive UPLC-Q-TOF-MS/MS for the Measurement of Nine Components in Rat Plasma and Tissues and its Application to Pharmacokinetics and Tissue Distribution Studies with Xuanfei Baidu Granules
Current Drug Metabolism Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot Topic: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Bisthiourea Derivatives of Dipeptide Conjugated Benzo[d]isoxazole as a New Class of Therapeutics: Synthesis and Molecular Docking Studies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Atrial Fibrosis Detected by Delayed - Enhancement MRI in Atrial Fibrillation Ablation
Current Medical Imaging Diversity in the Accessory Proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV Betacoronaviruses
Current Protein & Peptide Science On the Structural Basis of the Hypertensive Properties of Angiotensin II: A Solved Mystery or a Controversial Issue?
Current Topics in Medicinal Chemistry Fast Microwave Assisted Synthesis of Pyranopyrazole Derivatives as New Anticancer Agents
Current Microwave Chemistry Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
Current Medicinal Chemistry 1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities
Current Computer-Aided Drug Design Editorial
Current Drug Targets - Infectious Disorders New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication Cycle
Current Medicinal Chemistry Lung Defence Mechanisms and Their Potential Role in the Prevention of Ventilator Associated Pneumonia
Current Respiratory Medicine Reviews